Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Disruption of NIPBL/Scc2 in Cornelia de Lange Syndrome provokes cohesin genome-wide redistribution with an impact in the transcriptome

  • Garcia, Patricia
  • Fernandez-Hernandez, Rita
  • Cuadrado, Ana
  • Coca, Ignacio
  • Gomez, Antonio
  • Maqueda, Maria
  • Latorre-Pellicer, Ana
  • Puisac, Beatriz
  • Ramos, Feliciano J.
  • Sandoval, Juan
  • Esteller, Manel
  • Mosquera, Jose Luis
  • Rodriguez, Jairo
  • Pié, J.
  • Losada, Ana
  • Queralt, Ethel
Cornelia de Lange syndrome (CdLS) is a rare disease affecting multiple organs and systems during development. Mutations in the cohesin loader, NIPBL/Scc2, were first described and are the most frequent in clinically diagnosed CdLS patients. The molecular mechanisms driving CdLS phenotypes are not understood. In addition to its canonical role in sister chromatid cohesion, cohesin is implicated in the spatial organization of the genome. Here, we investigate the transcriptome of CdLS patient-derived primary fibroblasts and observe the downregulation of genes involved in development and system skeletal organization, providing a link to the developmental alterations and limb abnormalities characteristic of CdLS patients. Genome-wide distribution studies demonstrate a global reduction of NIPBL at the NIPBL-associated high GC content regions in CdLS-derived cells. In addition, cohesin accumulates at NIPBL-occupied sites at CpG islands potentially due to reduced cohesin translocation along chromosomes, and fewer cohesin peaks colocalize with CTCF.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

GATA2 Promotes Hematopoietic Development and Represses Cardiac Differentiation of Human Mesoderm

  • Castaño Cardoso, Julio|||0000-0002-0712-5856
  • Aranda, Sergi|||0000-0003-3853-430X
  • Bueno, Clara|||0000-0003-1442-6216
  • Calero-Nieto, Fernando|||0000-0003-3358-8253
  • Mejia-Ramirez, Eva|||0000-0003-1251-5223
  • Mosquera, José Luis|||0000-0002-7852-4993
  • Blanco, Enrique|||0000-0001-6261-7370
  • Wang, Xiaonan|||0000-0003-3759-778X
  • Prieto, Cristina|||0000-0002-0812-8100
  • Zabaleta, Lorea
  • Mereu, Elisabetta|||0000-0001-6101-8472
  • Rovira, Meritxell|||0000-0002-0538-4846
  • Jiménez-Delgado, Senda
  • Matson, Daniel Rusch|||0000-0003-1430-3128
  • Heyn, Holger|||0000-0002-3276-1889
  • Bresnick, Emery H.
  • Göttgens, Berthold|||0000-0001-6302-5705
  • Di Croce, Luciano|||0000-0003-3488-6228
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
  • Raya, Ángel|||0000-0003-2189-9775
  • Giorgetti, Alessandra|||0000-0001-5803-3567
In vertebrates, GATA2 is a master regulator of hematopoiesis and is expressed throughout embryo development and in adult life. Although the essential role of GATA2 in mouse hematopoiesis is well established, its involvement during early human hematopoietic development is not clear. By combining time-controlled overexpression of GATA2 with genetic knockout experiments, we found that GATA2, at the mesoderm specification stage, promotes the generation of hemogenic endothelial progenitors and their further differentiation to hematopoietic progenitor cells, and negatively regulates cardiac differentiation. Surprisingly, genome-wide transcriptional and chromatin immunoprecipitation analysis showed that GATA2 bound to regulatory regions, and repressed the expression of cardiac development-related genes. Moreover, genes important for hematopoietic differentiation were upregulated by GATA2 in a mostly indirect manner. Collectively, our data reveal a hitherto unrecognized role of GATA2 as a repressor of cardiac fates, and highlight the importance of coordinating the specification and repression of alternative cell fates.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Extramedullary multiple myeloma patient-derived orthotopic xenograft with a highly altered genome, Combined molecular and therapeutic studies

  • Farré, Lourdes|||0000-0002-3168-1940
  • Sanz-Linares, Gabriela|||0000-0001-7960-7988
  • Ruiz-Xivillé, Neus
  • Castro de Moura, Manuel|||0000-0002-8488-5306
  • Martin-Tejera, Juan Francisco|||0000-0002-8060-3578
  • Goncąlves-Ribeiro, Samuel|||0000-0002-0261-3965
  • Martinez-Iniesta, Maria
  • Calaf, Monica
  • Mosquera, José Luis|||0000-0002-7852-4993
  • Martin-Subero, Jose Ignacio|||0000-0001-8809-5195
  • Granada, Isabel|||0000-0002-4275-0104
  • Esteller, M.|||0000-0003-4490-6093
  • Domingo-Domenech, Eva|||0000-0001-8907-090X
  • Climent, Fina|||0000-0002-4360-8388
  • Villanueva, Alejandro|||0000-0001-5164-0006
  • Sureda, Anna|||0000-0002-1238-6970
Extramedullary multiple myeloma (EMM) has an overall survival of 6 months and occurs in 20% of multiple myeloma (MM) patients. Genetic and epigenetic mechanisms involved in EMM and the therapeutic role of new agents for MM are not well established. Besides, well-characterized preclinical models for EMM are not available. Herein, a patient-derived orthotopic xenograft (PDOX) was generated from a patient with an aggressive EMM to study in-depth genetic and epigenetic events, and drug responses related to extramedullary disease. A fresh punch of an extramedullary cutaneous lesion was orthotopically implanted in NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ(NSG) mouse. The PDOX mimicked histologic and phenotypic features of the tumor of the patient. Cytogenetic studies revealed a hyperploid genome with multiple genetic poor-prognosis alterations. Copy number alterations (CNAs) were detected in all chromosomes. The IGH translocation t(14;16)(q32;q23)IGH/MAF was already observed at the medullary stage and a new one, t(10;14)(p?11-12;q32), was observed only with extramedullary disease and could be eventually related to EMM progression in this case. Exome sequencing showed 24 high impact single nucleotide variants and 180 indels. From the genes involved, only TP53 was previously described as a driver in MM. A rather balanced proportion of hyper/hypomethylated sites different to previously reported widespread hypomethylation in MM was also observed. Treatment with lenalidomide, dexamethasone and carfilzomib showed a tumor weight reduction of 90% versus nontreated tumors, whereas treatment with the anti-CD38 antibody daratumumab showed a reduction of 46%. The generation of PDOX from a small EMM biopsy allowed us to investigate in depth the molecular events associated with extramedullary disease in combination with drug testing.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Disruption of NIPBL/Scc2 in Cornelia de Lange Syndrome provokes cohesin genome-wide redistribution with an impact in the transcriptome

  • Garcia, Patricia
  • Fernández Hernández, Rita
  • Cuadrado, Ana|||0000-0002-9752-5932
  • Coca, Ignacio
  • Gómez Moruno, Antonio|||0000-0001-5308-981X
  • Maqueda, Maria|||0000-0001-9304-1714
  • Latorre Pellicer, Ana|||0000-0002-4703-6620
  • Puisac, Beatriz|||0000-0003-0170-7326
  • Ramos, Feliciano J.|||0000-0002-5732-2209
  • Sandoval, Juan|||0000-0002-5100-973X
  • Esteller, M.|||0000-0003-4490-6093
  • Mosquera, José Luis|||0000-0002-7852-4993
  • Rodríguez, Jairo
  • Pié, Juan|||0000-0003-3203-6254
  • Losada, Ana|||0000-0001-5251-3383
  • Queralt, Ethel|||0000-0003-0045-0039
Cornelia de Lange syndrome (CdLS) is a rare disease affecting multiple organs and systems during development. Mutations in the cohesin loader, NIPBL/Scc2, were first described and are the most frequent in clinically diagnosed CdLS patients. The molecular mechanisms driving CdLS phenotypes are not understood. In addition to its canonical role in sister chromatid cohesion, cohesin is implicated in the spatial organization of the genome. Here, we investigate the transcriptome of CdLS patient-derived primary fibroblasts and observe the downregulation of genes involved in development and system skeletal organization, providing a link to the developmental alterations and limb abnormalities characteristic of CdLS patients. Genome-wide distribution studies demonstrate a global reduction of NIPBL at the NIPBL-associated high GC content regions in CdLS-derived cells. In addition, cohesin accumulates at NIPBL-occupied sites at CpG islands potentially due to reduced cohesin translocation along chromosomes, and fewer cohesin peaks colocalize with CTCF.